FFA
PRCT icon

Farther Finance Advisors’s Procept Biorobotics PRCT Stock Holding History

Farther Finance Advisors’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$9.66K Buy
530
+267
+102% +$5.32K ﹤0.01% 4638
2026
Q2 		$5.94K Sell
263
-625
-70% -$15.6K ﹤0.01% 4703
2026
Q1 		$22.5K Buy
888
+531
+149% +$15K ﹤0.01% 3579
2025
Q4 		$11.2K Buy
357
+319
+839% +$10.6K ﹤0.01% 3830
2025
Q3 		$1.36K Buy
38
+8
+27% +$365 ﹤0.01% 4275
2025
Q2 		$1.73K Buy
30
+6
+25% +$339 ﹤0.01% 3748
2025
Q1 		$1.37K Buy
24
+11
+85% +$751 ﹤0.01% 3519
2024
Q4 		$1.05K Hold
13
– – ﹤0.01% 3236
2024
Q3 		$1.04K Buy
13
+3
+30% +$213 ﹤0.01% 3232
2024
Q2 		$619 Buy
10
+5
+100% +$297 ﹤0.01% 3226
2024
Q1 		$235 Hold
5
– – ﹤0.01% 3232
2023
Q4 		$210 Hold
5
– – ﹤0.01% 3217
2023
Q3 		$164 Buy
+5
New +$170 ﹤0.01% 2493

Other funds holding PRCT

MCP
Mirador Capital Partners Pleasanton, California $859M AUM 41.74% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
EWP
Elevation Wealth Partners Santa Rosa, California $356M AUM 17.04% 1-Year Est. Return

Farther Finance Advisors's PRCT Position: Q3 2026 in Review

Farther Finance Advisors increased its Procept Biorobotics (PRCT) stake by 102% in Q3 2026, buying an estimated $5.32K and bringing the position to 530 shares worth $9.66K. The position accounts for ﹤0.01% of the portfolio, ranked #4638.

Farther Finance Advisors first reported a position in PRCT in Q3 2023 and has held it in 13 quarters since. The position peaked at $22.5K in Q1 2026. 7 funds tracked by Wall St. Rank hold PRCT as of Q3 2026.

  • Farther Finance Advisors held 530 shares of Procept Biorobotics worth $9.66K as of Q3 2026.
  • Farther Finance Advisors bought 267 Procept Biorobotics shares in Q3 2026, an estimated $5.32K.
  • Procept Biorobotics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #4638 holding.
  • Farther Finance Advisors first reported a position in Procept Biorobotics in Q3 2023 and has held it in 13 quarters since.
  • Farther Finance Advisors's Procept Biorobotics position peaked at $22.5K in Q1 2026.
  • 7 funds tracked by Wall St. Rank held Procept Biorobotics as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.